Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Getein BiotechSHSE:603387 +0.67%77 Dividend Yield % is 2.69% as of Aug. 02, 2026, which is 48% above its 10-year median of 1.82. GuruFocus rates SHSE:603387 with a GF Score™ of 77/100 and a GF Value™ of ¥7.57 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 318 Medical Devices & Instruments companies, Getein Biotech ranks better than 64.78% on this metric.
As of today (2026-08-02), the Trailing Annual Dividend Yield of Getein Biotech is 2.69%.
Good Sign:
Getein Biotech Inc stock Dividend Yield % is close to 2-year high.
The historical rank and industry rank for Getein Biotech's Dividend Yield % or its related term are showing as below:
SHSE:603387'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.54 Med: 1.82 Max: 5.15
Current: 2.69
During the past 13 years, the highest Dividend Yield of Getein Biotech was 5.15%. The lowest was 0.54%. And the median was 1.82%.
SHSE:603387's Dividend Yield % is ranked better than 64.78% of 318
companies
in the Medical Devices & Instruments industry
Industry Median: 1.995
vs SHSE:603387: 2.69
During the past 12 months, Getein Biotech's average Dividends Per Share Growth Rate was -5.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -19.10% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -1.00% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Getein Biotech was 31.70% per year. The lowest was -19.10% per year. And the median was 16.30% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Getein Biotech's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603387 vs ABT, SYK, MDT: Dividend Yield % Comparison
For the Medical Devices subindustry, Getein Biotech's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Getein Biotech Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Getein Biotech's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Getein Biotech's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Getein Biotech Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.150000
2026-06-18
2026-06-17
2026-06-18
Cash Dividend
semi-annually
CNY:CNY 1.000000
CNY 0.090000
2025-09-15
2025-09-12
2025-09-15
Cash Dividend
semi-annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Getein Biotech's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Getein Biotech (SHSE:603387) has a Dividend Yield % of 2.69% as of Aug. 02, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Getein Biotech and its competitors. This is 48% above median its historical median of 1.82. Over the past decade, Getein Biotech's Dividend Yield % has ranged from 0.54 to 5.15. According to the industry distribution chart, Getein Biotech ranks #112 out of 318 companies in the Medical Devices & Instruments industry, placing it in the top 35.2%.
Is Getein Biotech's Dividend Yield % too high?
Getein Biotech's current Dividend Yield % of 2.69% is 48% above median its 10-year median of 1.82. Over the past 10 years, this metric has ranged from a low of 0.54 to a high of 5.15. The Medical Devices & Instruments industry median Dividend Yield % is 2.00. Getein Biotech's value of 2.69% is 34.8% above this industry median. Based on the distribution chart, Getein Biotech ranks #112 out of 318 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Getein Biotech has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Getein Biotech's Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Getein Biotech ranks #112 out of 318 companies for Dividend Yield %. This puts Getein Biotech in the upper half of its industry. The industry median Dividend Yield % is 2.00. Getein Biotech's value of 2.69% is 34.8% above this benchmark. Historically, Getein Biotech's own Dividend Yield % has ranged from 0.54 to 5.15 over the past decade. While the company's 10-year median is 1.82 vs. the industry median of 2.00, Getein Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 2.00, based on 318 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Getein Biotech's current Dividend Yield % of 2.69% is 34.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Getein Biotech and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Getein Biotech's current Dividend Yield % is 2.69%, which is 48% above median its own 10-year median of 1.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Getein Biotech stock overvalued right now?
Based on GuruFocus' analysis, Getein Biotech (SHSE:603387) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥7.57, compared to a current price of ¥8.96 — trading 18.4% above its estimated fair value. The current Dividend Yield % is 2.69%, which is 48% above median its 10-year median of 1.82 and 34.8% above the Medical Devices & Instruments industry median of 2.00. Getein Biotech's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Getein Biotech (SHSE:603387), the current Dividend Yield % is 2.69% as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Getein Biotech (SHSE:603387) Overvalued in 2026?
Based on GuruFocus' analysis, Getein Biotech stock appears to be overvalued.
The current stock price of ¥8.96 is trading 18.4% above its estimated GF Value™ of ¥7.57.
GuruFocus considers Getein Biotech to be Modestly Overvalued.
Key valuation signals for SHSE:603387:
Dividend Yield %: 2.69% (48% above median its 10-year median of 1.82)
GF Value™: ¥7.57 vs. price of ¥8.96 (18.4% above fair value)
Industry Position: 34.8% above the Medical Devices & Instruments median (#112 of 318)
No single metric tells the full story. See the SHSE:603387 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Getein Biotech Inc is an in-vitro diagnostic company. It is specializing in analytical medical devices and point-of-care testing kits. Its product lines consist of cardiovascular, inflammatory, diabetes, fertility, renal, liver and specialty assays.
77GF Score
Get the complete analysis for SHSE:603387
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603387 has been successfully added to your 
